Those wacky animal rights maniactivists get up in arms because they think animals are being tortured as part of the pharma R&D process. I’m more concerned about how their executives mangle our language, as illustrated by this morning’s gem:
We are proactively managing our total cost structure to do what is necessary to size the company appropriately to align with our revenues so that we deliver growing profitability after the Lipitor loss of exclusivity.
–Frank D’Amelio, chief financial officer, Pfizer, Inc.